MoonLake Immunotherapeutics
MLTX
#5641
Rank
A$1.85 B
Marketcap
A$26.14
Share price
-3.43%
Change (1 day)
-64.46%
Change (1 year)

Earnings for MoonLake Immunotherapeutics (MLTX)

Earnings in 2025 (TTM): -A$0.33 Billion

According to MoonLake Immunotherapeutics's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -A$0.19 Billion a decrease over its 2023 earnings that were of -A$80.97 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for MoonLake Immunotherapeutics from 2022 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -A$0.33 Billion76.72%
2024 -A$0.19 Billion129.45%
2023 -A$80.97 Million-16.81%
2022 -A$97.34 Million